In early 2024, Breakthrough T1D launched an initiative to advance kidney research in type 1 diabetes
Surgeon 3:309316 Petek M, Sikiric P, Anic T, Buljat G, eparovic J, Stancic-Rokotov D, Seiwerth S, Grabarevic Z, Rucman R, Mikus D, Zoricic I (1999) Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice
These medicines work by mimicking the action of a naturally occurring hormone called GLP-1, which is released from the intestine in response to food intake
We examined their prescription and discontinuation patterns in irritable bowel syndrome (IBS) patients
For many people, the long-term cardiovascular and metabolic benefits of maintaining a healthy weight outweigh the risks of continued medication